Back to Search VC Home Page
Venture Capital Search Engine
search over 1,000 Venture Capital related sites
Keywords about VC:  

Easton Hunt Capital Partners

1.Easton Capital Investment Group::home page   (100%):
strategy funds team portfolio contact us Easton Capital Investment Group manages approximately $140 million on behalf of a number of significant institutional investors in its two funds, Easton Hunt Capital Partners, L.P. and Easton Hunt New York LP. Easton makes investments ranging in size from $2...
2.Easton Capital Investment Group::home page   (100%):
strategy funds team portfolio contact us Easton Capital Investment Group manages approximately $140 million on behalf of a number of significant institutional investors in its two funds, Easton Hunt Capital Partners, L.P. and Easton Hunt New York LP. Easton makes investments ranging in size from $2...
3.Easton Capital Investment Group::funds   (73%):
The Easton Capital Investment Group Easton Capital Investment Group manages approximately $140 million of venture capital and private equity funds. Aggregating more than 170 years of experience, its principals focus on a broadly defined vision of investing in undervalued companies in undervalued mar...
4.Easton Capital Investment Group::strategy   (65%):
"In May 2003, Easton led a $55.3 million financing for Acorda Therapeutics, one of the top three private biotechnology financings to date in 2003. Easton's ability to lead such a significant round, particularly in a challenging financial environment, is a testament to its capabilities and exce...
5.Easton Capital Investment Group::traditional business portfolio   (61%):
" Easton Hunt Capital Partners has been an excellent partner for SunSource. In addition to sound advice regarding financial matters, we benefit from their efforts to understand our business and help us position SunSource for strategic growth opportunities." Justin M. Jacobi CEO, SunSource
6.Easton Hunt Investment Group::portfolio   (57%):
Easton invests in proven management teams targeting growing markets, with strong franchises, dominant or proprietary product lines, and/or other sustainable competitive advantages. Investments can be categorized into: "Easton Hunt brings a diversity of business experience to the investment proc...
7.Easton Capital Investment Group::Mark D. Chen   (49%):
Partners John H. Friedman Mark D. Chen Francisco A. Garcia Charles B. Hughes III Edward J. Meyer Richard P. Schneider Sunny Sharma, MD Venture Partner Seth J Orlow, MD, PhD Vice President Daniel B. Googel Advisors Lawrence M. Kauvar, PhD Janice L. Garbrilove, MD Roman Perez-Soler, MD Office Manager...
8.Easton Capital Investment Group::SunSource Technology Services   (47%):
Easton Hunt Capital Partners has been an excellent partner for SunSource. In addition to sound advice regarding financial matters, we benefit from their efforts to understand our business and help us position SunSource for strategic growth opportunities." Justin M. Jacobi CEO, SunSource SunSou...
9.Easton Capital Investment Group::Depomed Inc.   (45%):
"We are delighted to have Easton Hunt Capital Partners as an investor and strong supporter of DepoMed. They are active advisors and welcome participants and contributors to our Board discussions, especially on strategic growth issues. Importantly also, their connections in the financial and bio...
10.Easton Capital Investment Group::Daniel B. Googel   (39%):
Partners John H. Friedman Mark D. Chen Francisco A. Garcia Charles B. Hughes III Edward J. Meyer Richard P. Schneider Sunny Sharma, MD Venture Partner Seth J Orlow, MD, PhD Vice President Daniel B. Googel Advisors Lawrence M. Kauvar, PhD Janice L. Garbrilove, MD Roman Perez-Soler, MD Office Manager...
11.Ridgewood   (38%):
Comverge is the leading supplier of load control systems and smart meters to hundreds of Power Utility Companies nationwide. Comverge load control products enable Power Companies to reduce the peak demand for power in specific localities to avoid transmission and generation overloads. Comverge smart...
12.Easton Capital Investment Group::Sunny Sharma, MD   (38%):
Partners John H. Friedman Mark D. Chen Francisco A. Garcia Charles B. Hughes III Edward J. Meyer Richard P. Schneider Sunny Sharma, MD Venture Partner Seth J Orlow, MD, PhD Vice President Daniel B. Googel Advisors Lawrence M. Kauvar, PhD Janice L. Garbrilove, MD Roman Perez-Soler, MD Office Manager...
13.Easton Capital Investment Group::contact informaton   (37%):
"We are delighted to have Easton Hunt Capital Partners as an investor and strong supporter of DepoMed. They are active advisors and welcome participants and contributors to our Board discussions, especially on strategic growth issues. Importantly also, their connections in the financial and bi...
14.Hunt Family Affiliations   (35%):
In addition to Hunt Ventures, Ray L. Hunt and members of his family have common ownership in, or are affiliated with, Hunt Oil Company, Hunt Realty Corporation, Hunt Refining Company, Hunt Equities, Hunt Investment Group, Hunt Power, Hunt Private Equity Group, Hunt Resources, and significant other ...
15.Hunt Family Affiliations   (34%):
Ray L. Hunt and members of his family have common ownership in, or are affiliated with, Hunt Private Equity Group, Hunt Ventures LP, Hunt Equities, Hunt Resources, Inc., Hunt Oil Company, Hunt Realty Corporation, Hunt Special Situations Group, and significant other holdings including various oil an...
16.Welcome to Academy Funds   (33%):
Academy Funds (Academy Ventures) is a family of venture capital funds focused on achieving outstanding investment returns in seed and early-stage companies. The following is a partial list of companies/institutions that have co-invested in and/or partnered with Academy portfolio companies: Advent V...
17.Easton Capital Investment Group::Edward J. Meyer   (32%):
Partners John H. Friedman Mark D. Chen Francisco A. Garcia Charles B. Hughes III Edward J. Meyer Richard P. Schneider Sunny Sharma, MD Venture Partner Seth J Orlow, MD, PhD Vice President Daniel B. Googel Advisors Lawrence M. Kauvar, PhD Janice L. Garbrilove, MD Roman Perez-Soler, MD Office Manager...
18.easton Capital Investment Group::Acorda Therapeutics   (31%):
"In May 2003, Easton led a $55.3 million financing for Acorda Therapeutics, one of the top three private biotechnology financings to date in 2003. Easton s ability to lead such a significant round, particularly in a challenging financial environment, is a testament to its capabilities and excel...
19.Acorda :: Current Investors   (30%):
Acorda Therapeutics is a privately held biotechnology company devoted to developing therapies for individuals with spinal cord injury, multiple sclerosis, and related disorders of the nervous system. Since its inception in 1995, Acorda has raised over $140 million through a combination of individua...
20.Hunt Private Equity Group   (30%):
Hunt Private Equity Group, Inc. represents a unique investment partner for established middle market companies. In every case in which we acquirea a business or provide expansion capital, we seek to create a partnership with management focused on long-term value creation. As a member of the Hunt fam...

Page: 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20  

VC Directory: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others